Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery

Surgery Today

Volumn 40, Issue 7, 2010, Pages 626-631

  Saeki, Hiroshi ^a   Masuda, Takanobu ^a   Okada, Satoko ^a   Ando, Koji ^a   Sugiyama, Masahiko ^a   Yoshinaga, Keiji ^a   Endo, Kazuya ^a   Sadanaga, Noriaki ^a   Emi, Yasunori ^a,b   Kakeji, Yoshihiro ^a   Morita, Masaru ^a   Yamashita, Natsumi ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Esophagectomy; Factor XIII; Leakage; Pneumonia; Preoperative therapy; Transferrin

Indexed keywords

BLOOD CLOTTING FACTOR 13; CISPLATIN; D DIMER; FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; FLUOROURACIL; TRANSFERRIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS SURGERY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTION; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL; ADJUVANT THERAPY; ANASTOMOSIS; BLOOD; ESOPHAGEAL NEOPLASMS; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PREDICTIVE VALUE; PROGNOSIS; SURGICAL WOUND DEHISCENCE;

AGED; ANASTOMOSIS, SURGICAL; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FACTOR XIII; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURGICAL WOUND DEHISCENCE; TRANSFERRIN;

EID: 77955616594     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4135-1     Document Type: Article

References (26)

1. P.C. Wu M. Posner 2003 The role of surgery in the management of oesophageal cancer Lancet Oncol 4 481 488 10.1016/S1470-2045(03)01167-7 12901962 (Pubitemid 37009956)
2. G.G. Jamieson G. Mathew R. Ludemann J. Wayman J.C. Myers P.G. Devitt 2004 Postoperative mortality following oesophagectomy and problem in reporting its rate Br J Surg 9 943 947 10.1002/bjs.4596 (Pubitemid 39070806)
3. M. Morita R. Yoshida K. Ikeda A. Egashira E. Oki N. Sadanaga, et al. 2008 Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute Surgery 143 499 508 10.1016/j.surg.2007. 12.007 18374047
4. T. Shichinohe S. Hirano S. Kondo 2008 Video-assisted esophagectomy for esophageal cancer Surg Today 38 206 213 10.1007/s00595-007-3606-5 18306993 (Pubitemid 351328111)
5. S.H. Li Z. Wang X.Y. Liu F.Y. Liu Z.Y. Sun H. Xue 2007 Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer Surg Today 37 1047 1052 10.1007/s00595-007-3548-y 1:CAS:528:DC%2BD2sXhsVygs77K 18030564 (Pubitemid 350165679)
6. S. Y. Law M. Fok J. Wong 1994 Risk analysis in resection of squamous cell carcinoma of the esophagus World J Surg 18 339 346 10.1007/BF00316812 1:STN:280:DyaK2cznvVKhug%3D%3D 8091773 (Pubitemid 24215030)
7. M.K. Ferguson T.R. Martin L.B. Reeder F.Y. Liu Z.Y. Sun H. Xue 1997 Mortality after esophagectomy: risk factor analysis World J Surg 21 599 603 10.1007/s002689900279 1:STN:280:DyaK2sznsVajtA%3D%3D 9230656 (Pubitemid 27268555)
8. B.P. Whooley S. Law S.C. Murthy A. Alexandrou J. Wong 2001 Analysis of reduced death and complication rates after esophageal resection Ann Surg 233 338 344 10.1097/00000658-200103000-00006 1:STN:280:DC%2BD3M7ps1elsA%3D%3D 11224620 (Pubitemid 32187811)
9. M. Fagevik Olsen E. Wennberg K. Josefson H. Lönroth L. Lundell 2002 Randomized clinical study of the prevention of pulmonary complications after thoracoabdominal resection by two different breathing techniques Br J Surg 89 1228 1234 10.1046/j.1365-2168.2002.02207.x 1:STN:280:DC%2BD38vos1Crug%3D%3D 12296888 (Pubitemid 36002538)
10. S.T. Fan W.Y. Lau W.C. Yip G.P. Poon C. Yeung W.K. Lam, et al. 1987 Prediction of postoperative pulmonary complications in oesophagogastric cancer surgery Br J Surg 74 408 410 10.1002/bjs.1800740530 1:STN:280: DyaL2s3ktlaitA%3D%3D 3594139 (Pubitemid 17080900)
11. S.Y. Law M. Fok J. Wong 1994 Risk analysis in resection of squamous cell carcinoma of the esophagus World J Surg 18 339 346 10.1007/BF00316812 1:STN:280:DyaK2cznvVKhug%3D%3D 8091773 (Pubitemid 24215030)
12. O. Lund H.H. Kimose M.T. Aagaard J.M. Hasenkam M. Erlandsen 1990 Risk stratification and long-term results after surgical treatment of carcinomas of the thoracic esophagus and cardia. A 25-year retrospective study J Thorac Cardiovasc Surg 99 200 209 1:STN:280:DyaK3c7jsFansA%3D%3D 2299857
13. H. Bartels H.J. Stein J.R. Siewert 1998 Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer Br J Surg 85 840 844 10.1046/j.1365-2168.1998.00663.x 1:STN:280:DyaK1czjtVaqtg%3D%3D 9667720 (Pubitemid 28300521)
14. J.F. Bosset M. Gignoux J.P. Triboulet E. Tiret G. Mantion D. Elias, et al. 1997 Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 227 161 167 10.1056/NEJM199707173370304 (Pubitemid 27306287)
15. C.E. Avendano P.A. Flume G.A. Silvesri L.B. King C.E. Reed 2002 Pulmonary complications after esophagectomy Ann Thorac Surg 73 922 926 10.1016/S0003-4975(01)03584-6 11899202 (Pubitemid 34189282)
16. U. Fink H.J. Stein H. Wilke 1995 Multimodal treatment for squamous cell esophageal cancer World J Surg 19 198 204 10.1007/BF00308626 1:STN:280:DyaK2M3nsVagtg%3D%3D 7754623
17. S. Law K. Wong K. Kwak K.M. Chu J. Wong 2004 Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer Ann Surg 240 791 800 10.1097/01.sla.0000143123.24556.1c 15492560 (Pubitemid 39425771)
18. S.T. Kelley D. Coppola R.C. Karl 2004 Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs surgery alone in patients undergoing esophagectomy J Gastrointest Surg 8 227 232 10.1016/j.gassur.2003.11. 024 15019913 (Pubitemid 38344154)
19. F.C. Lin A.E. Durkin M.K. Ferguson 2004 Induction therapy does not increase surgical morbidity after esophagectomy for cancer Ann Thorac Surg 78 1783 1789 10.1016/j.athoracsur.2004.04.081 15511475 (Pubitemid 39423555)
20. S. Tsutsui M. Morita H. Kuwano H. Matsuda M. Mori S. Okamura, et al. 1992 Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma J Surg Oncol 49 176 181 10.1002/jso.2930490310 1:STN:280:DyaK387psVOmsg%3D%3D 1372377
21. M. Morita R. Yoshida K. Ikeda A. Egashira E. Oki N. Sadanaga, et al. 2008 Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid Dis Esophagus 21 30 36 1:STN:280: DC%2BD1c%2FksVentA%3D%3D 18197936
22. S. Akamoto K. Okano T. Sano S. Yachida K. Izuishi H. Usuki, et al. 2007 Neutrophil elastase inhibitor (Sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery Surg Today 37 359 365 10.1007/s00595-006-3409-0 1:CAS:528:DC%2BD2sXkslWnsr4%3D 17468814 (Pubitemid 46684518)
23. J. Xu Y. Zhong D. Jing Z. Wu 2006 Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer World J Surg 30 1284 1289 10.1007/s00268-005-0756-8 16830214 (Pubitemid 44078418)
24. K. Laki L. Lóránd 1948 On the solubility of fibrin clots Science 108 280 10.1126/science.108.2802.280 1:STN:280:DC%2BC3czosVGhsQ%3D%3D 17842715
25. S. Canonico 2003 The use of human fibrin glue in the surgical operations Acta Biomed 74 21 25 15055028
26. K. Azim R. McManus K. Brophy A. Ryan D. Kelleher J.V. Reynolds 2007 Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype Ann Surg 246 122 128 10.1097/01.sla.0000259389.09161.49 17592300 (Pubitemid 47012216)